Aspire Hayfever Relief 2% eye drops

Država: Velika Britanija

Jezik: engleski

Izvor: MHRA (Medicines & Healthcare Products Regulatory Agency)

Kupi sada

Preuzimanje Svojstava lijeka (SPC)
05-07-2018

Aktivni sastojci:

Sodium cromoglicate

Dostupno od:

Aspire Pharma Ltd

ATC koda:

S01GX01

INN (International ime):

Sodium cromoglicate

Doziranje:

20mg/1ml

Farmaceutski oblik:

Eye drops

Administracija rute:

Ocular

Razred:

No Controlled Drug Status

Tip recepta:

Valid as a prescribable product

Proizvod sažetak:

BNF: 11040200; GTIN: 5060209731360

Svojstava lijeka

                                OBJECT 1
HAYFEVER RELIEF 2%W/V EYE DROPS
Summary of Product Characteristics Updated 04-Apr-2018 | Aspire Pharma
Ltd
1. Name of the medicinal product
Aspire Hayfever Relief 2% w/v Eye Drops, solution
Boots Hayfever Relief 2% w/v Eye Drops, solution
Numark Hayfever Relief 2% w/v Eye Drops, solution
Optrex Hayfever Relief 2%w/v Eye Drops, solution
EM Pharma Hayfever Relief 2%w/v Eye Drops, solution
Pollenase Hayfever Relief 2%w/v Eye Drops, solution
Opticrom Hayfever 2%w/v Eye Drops, solution
2. Qualitative and quantitative composition
Each ml of eye drops contains
Active substance: 20 mg sodium cromoglicate (2.0% w/v), (one drop
contains 0.7mg sodium
cromoglicate).
Excipient with known effect: 0.1mg benzalkonium chloride
For a full list of excipients, see section 6.1.
3. Pharmaceutical form
Eye Drops, Solution (eye drops)
Clear colourless to pale yellow solution
4. Clinical particulars
4.1 Therapeutic indications
For the relief and treatment of the eye symptoms of hayfever.
4.2 Posology and method of administration
Sodium cromoglicate 2%w/v eye drops should not be used continuously
for more than 14 days except on
the advice of a doctor or pharmacist.
Ocular use
Adults and Children over 6 years:
One or two drops to be administered into each eye four times daily.
Children under 6 years
There is no relevant indication for use of sodium cromoglicate in
children. Sodium cromoglicate is
contraindicated in children under 2 years of age.
Elderly
There is no evidence to suggest that dosage alteration is required for
elderly patients.
4.3 Contraindications
Hypersensitivity to the active substance or to any of the excipients
4.4 Special warnings and precautions for use
Discard any remaining contents four weeks after opening the bottle.
Sodium cromoglicate eye drops contain benzalkonium chloride.
May cause eye irritation.
Avoid contact with soft contact lenses.
Remove contact lenses prior to application and wait at least 15
minutes before reinsertion.
Known to discolour soft contact lenses.
The carton and patient information l
                                
                                Pročitajte cijeli dokument
                                
                            

Upozorenja za pretraživanje vezana za ovaj proizvod